Freshpet (FRPT) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
31 Aug, 2026Executive summary
Net sales for Q2 2026 increased 15.5% year-over-year to $305.6 million, driven by volume gains and strong omni-channel expansion, with the highest adjusted gross margin since Q1 2020.
Adjusted EBITDA for Q2 2026 was $52.2 million, up from $44.4 million in the prior year, with margin at 17.1%.
Net income rose to $19.5 million from $16.4 million year-over-year, aided by a gain on equity investment and higher sales.
Digital orders grew 41% in Q2, now 16.7% of total business, with strong DTC and e-commerce performance.
Market share in US dog food and treats reached 4.3%, with growth driven by MVP consumers and generational shifts.
Financial highlights
Adjusted gross margin improved to 48.6% from 46.9% a year ago, a 170 basis point increase.
Operating cash flow for Q2 2026 grew 31% to $44.4 million; free cash flow was $14.7 million.
Cash and cash equivalents as of June 30, 2026, were $350.8 million, up from $278.0 million at year-end 2025.
SG&A expenses increased to $107.0 million (35.0% of net sales), with adjusted SG&A at 31.4%.
Net income per diluted share was $0.39 in Q2 2026, up from $0.33 year-over-year.
Outlook and guidance
2026 net sales growth guidance raised to 10–12% (from 8–11%).
Adjusted EBITDA guidance increased to $210–220 million, up 7–12% year-over-year.
Adjusted gross margin expected to improve by 100–150 basis points in 2026.
2027 targets: at least 49% adjusted gross margin and 20–22% adjusted EBITDA margin.
Capital expenditures projected at $150 million for 2026.
Latest events from Freshpet
- Omni-channel growth, innovation, and margin expansion position the business to lead fresh pet food.FRPT
Barclays 19th Annual Global Consumer Conference - Q1 2026 net sales up 13.1%, net income $48.5M, and guidance raised on digital and margin gains.FRPT
Q1 2026 - 2025 net sales rose 13% to $1.1B, with strong cash flow and 2026 growth guidance of 7–10%.FRPT
Q4 2025 - Q3 2025 sales up 14%, EBITDA and net income surge, free cash flow positive, guidance narrowed.FRPT
Q3 2025 - Q2 2025 net sales rose 12.5% with margin gains, capex cuts, and reaffirmed profitability targets.FRPT
Q2 2025 - Q3 net sales up 26%, margins expanded, and 2024 guidance raised on strong execution.FRPT
Q3 2024 - Q2 2024 net sales up 28.3% with margin gains and raised full-year guidance.FRPT
Q2 2024 - Q1 net sales up 18%, but net loss and reduced outlook reflect higher costs and headwinds.FRPT
Q1 2025 - Record sales, margin gains, and first positive net income drive upgraded long-term targets.FRPT
Q4 2024